Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment ; volume:10 ; number:3 ; day:20 ; month:4 ; year:2012 ; pages:1 ; date:12.2012
Hereditary cancer in clinical practice ; 10, Heft 3 (20.4.2012), 1, 12.2012
- Urheber
-
Byrski, T.
- Beteiligte Personen und Organisationen
-
Gronwald, J.
Huzarski, T.
Marczyk, E.
Blecharz, P.
Ashuryk, O.
Cybulski, C.
Zuziak, D.
Wiśniowski, R.
Godlewski, D.
Narod, SA
Lubinski, J.
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-10-S3-A3
- URN
-
urn:nbn:de:1111-2016073118363
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Byrski, T.
- Gronwald, J.
- Huzarski, T.
- Marczyk, E.
- Blecharz, P.
- Ashuryk, O.
- Cybulski, C.
- Zuziak, D.
- Wiśniowski, R.
- Godlewski, D.
- Narod, SA
- Lubinski, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cisplatin in breast cancer treatment in BRCA1 carriers
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Folic acid and cancer risk in BRCA1 carriers
Effectiveness of neoadjuvant chemotherapy with a docetaxel, cisplatin, and S-1 (DCS) regimen for T4b gastric cancer
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Cisplatin in breast cancer treatment in BRCA1 carriers
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Folic acid and cancer risk in BRCA1 carriers
Effectiveness of neoadjuvant chemotherapy with a docetaxel, cisplatin, and S-1 (DCS) regimen for T4b gastric cancer
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Cisplatin in breast cancer treatment in BRCA1 carriers
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Folic acid and cancer risk in BRCA1 carriers
Effectiveness of neoadjuvant chemotherapy with a docetaxel, cisplatin, and S-1 (DCS) regimen for T4b gastric cancer
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin